Cargando…
COVID-19 acute respiratory distress syndrome: can iloprost have a role for the treatment?
Pulmonary infection of 2019-nCoV can frequently induce acute respiratory distress syndrome (ARDS) with partial pressure of arterial oxygen/fraction of inspired oxygen ratio (pO2/FiO2) of less than 300 mmHg. Moreover, it can be complicated with cardiac injury or arrhythmia, microvascular and large-ve...
Autores principales: | Filippini, Alida, Bnà, Claudio, Bellosta, Raffaello, Bazzani, Roberto, Luzzani, Luca, Pegorer, Matteo Alberto, Zandalasini, Matteo, Baldon, Michela, Codazzi, Manuela, Sabatini, Tony |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847284/ https://www.ncbi.nlm.nih.gov/pubmed/33552890 http://dx.doi.org/10.1016/j.rmcr.2021.101358 |
Ejemplares similares
-
Dark sputum: An atypical presentation of primary pulmonary malignant melanoma
por: Filippini, Alida, et al.
Publicado: (2015) -
Major cardiovascular events in patients with Coronavirus Disease 2019: Experience of a cardiovascular department of Northern Italy()
por: Bellosta, Raffaello, et al.
Publicado: (2021) -
Acute limb ischemia in patients with COVID-19 pneumonia
por: Bellosta, Raffaello, et al.
Publicado: (2020) -
Effects of inhaled iloprost on acute respiratory distress syndrome in prone and supine positions
por: Senturk, E, et al.
Publicado: (2009) -
Inhaled iloprost improves gas exchange in patients with COVID-19 and acute respiratory distress syndrome
por: Tsareva, Natalia A., et al.
Publicado: (2021)